Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.

Pulmonary arterial hypertension (PAH) is characterized by progressive increases in vascular resistance and the remodeling of pulmonary arteries. The accumulation of inflammatory cells in the lung and elevated levels of inflammatory cytokines in the bloodstream suggest that inflammation may play a ro...

Full description

Bibliographic Details
Main Authors: Wei-Chun Huang, Meng-Wei Ke, Chin-Chang Cheng, Shih-Hwa Chiou, Shue-Ren Wann, Chih-Wen Shu, Kuan-Rau Chiou, Ching-Jiunn Tseng, Hung-Wei Pan, Guang-Yuan Mar, Chun-Peng Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4740504?pdf=render
id doaj-5fd8fc650c74494eb076070a76102068
record_format Article
spelling doaj-5fd8fc650c74494eb076070a761020682020-11-25T02:23:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014247610.1371/journal.pone.0142476Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.Wei-Chun HuangMeng-Wei KeChin-Chang ChengShih-Hwa ChiouShue-Ren WannChih-Wen ShuKuan-Rau ChiouChing-Jiunn TsengHung-Wei PanGuang-Yuan MarChun-Peng LiuPulmonary arterial hypertension (PAH) is characterized by progressive increases in vascular resistance and the remodeling of pulmonary arteries. The accumulation of inflammatory cells in the lung and elevated levels of inflammatory cytokines in the bloodstream suggest that inflammation may play a role in PAH. In this study, the benefits of induced pluripotent stem cells (iPSCs) and iPSC-conditioned medium (iPSC CM) were explored in monocrotaline (MCT)-induced PAH rats. We demonstrated that both iPSCs and iPSC CM significantly reduced the right ventricular systolic pressure and ameliorated the hypertrophy of the right ventricle in MCT-induced PAH rats in models of both disease prevention and disease reversal. In the prevention of MCT-induced PAH, iPSC-based therapy led to the decreased accumulation of inflammatory cells and down-regulated the expression of the IL-1β, IL-6, IL-12α, IL-12β, IL-23 and IFNγ genes in lung specimens, which implied that iPSC-based therapy may be involved in the regulation of inflammation. NF-κB signaling is essential to the inflammatory cascade, which is activated via the phosphorylation of the NF-κB molecule. Using the chemical inhibitor specifically blocked the phosphorylation of NF-κB, and in vitro assays of cultured human M1 macrophages implied that the anti-inflammation effect of iPSC-based therapy may contribute to the disturbance of NF-κB activation. Here, we showed that iPSC-based therapy could restore the hemodynamic function of right ventricle with benefits for preventing the ongoing inflammation in the lungs of MCT-induced PAH rats by regulating NF-κB phosphorylation.http://europepmc.org/articles/PMC4740504?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Wei-Chun Huang
Meng-Wei Ke
Chin-Chang Cheng
Shih-Hwa Chiou
Shue-Ren Wann
Chih-Wen Shu
Kuan-Rau Chiou
Ching-Jiunn Tseng
Hung-Wei Pan
Guang-Yuan Mar
Chun-Peng Liu
spellingShingle Wei-Chun Huang
Meng-Wei Ke
Chin-Chang Cheng
Shih-Hwa Chiou
Shue-Ren Wann
Chih-Wen Shu
Kuan-Rau Chiou
Ching-Jiunn Tseng
Hung-Wei Pan
Guang-Yuan Mar
Chun-Peng Liu
Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
PLoS ONE
author_facet Wei-Chun Huang
Meng-Wei Ke
Chin-Chang Cheng
Shih-Hwa Chiou
Shue-Ren Wann
Chih-Wen Shu
Kuan-Rau Chiou
Ching-Jiunn Tseng
Hung-Wei Pan
Guang-Yuan Mar
Chun-Peng Liu
author_sort Wei-Chun Huang
title Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
title_short Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
title_full Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
title_fullStr Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
title_full_unstemmed Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
title_sort therapeutic benefits of induced pluripotent stem cells in monocrotaline-induced pulmonary arterial hypertension.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Pulmonary arterial hypertension (PAH) is characterized by progressive increases in vascular resistance and the remodeling of pulmonary arteries. The accumulation of inflammatory cells in the lung and elevated levels of inflammatory cytokines in the bloodstream suggest that inflammation may play a role in PAH. In this study, the benefits of induced pluripotent stem cells (iPSCs) and iPSC-conditioned medium (iPSC CM) were explored in monocrotaline (MCT)-induced PAH rats. We demonstrated that both iPSCs and iPSC CM significantly reduced the right ventricular systolic pressure and ameliorated the hypertrophy of the right ventricle in MCT-induced PAH rats in models of both disease prevention and disease reversal. In the prevention of MCT-induced PAH, iPSC-based therapy led to the decreased accumulation of inflammatory cells and down-regulated the expression of the IL-1β, IL-6, IL-12α, IL-12β, IL-23 and IFNγ genes in lung specimens, which implied that iPSC-based therapy may be involved in the regulation of inflammation. NF-κB signaling is essential to the inflammatory cascade, which is activated via the phosphorylation of the NF-κB molecule. Using the chemical inhibitor specifically blocked the phosphorylation of NF-κB, and in vitro assays of cultured human M1 macrophages implied that the anti-inflammation effect of iPSC-based therapy may contribute to the disturbance of NF-κB activation. Here, we showed that iPSC-based therapy could restore the hemodynamic function of right ventricle with benefits for preventing the ongoing inflammation in the lungs of MCT-induced PAH rats by regulating NF-κB phosphorylation.
url http://europepmc.org/articles/PMC4740504?pdf=render
work_keys_str_mv AT weichunhuang therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT mengweike therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT chinchangcheng therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT shihhwachiou therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT shuerenwann therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT chihwenshu therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT kuanrauchiou therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT chingjiunntseng therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT hungweipan therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT guangyuanmar therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
AT chunpengliu therapeuticbenefitsofinducedpluripotentstemcellsinmonocrotalineinducedpulmonaryarterialhypertension
_version_ 1724858491672199168